Evidence map›Paper›PMID 41770883›Full record

ArticleJournal of medical virology2026

Increase of GII.17 Norovirus Infections During the 2024-2025 Season in Multiple Cities, China.

Wenjing Zheng, Xinyue Mu, Shaoyan Wang, Tianyi Qiu, Xuanyi Wang

Abstract read
In one paragraph

Article in Journal of medical virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wenjing ZhengInstitutes of Biomedical Sciences, Fudan University, Shanghai, China.ORCID https://orcid.org/0009-0000-5692-5959
Xinyue MuInstitutes of Biomedical Sciences, Fudan University, Shanghai, China.
Shaoyan WangIntelligent Medical Institute, Fudan University, Shanghai, China.
Tianyi QiuInstitute of Clinical Science, Clinical Center of Biotherapy, Zhongshan Hospital, Shanghai Institute of Infectious Disease and Biosecurity, Intelligent Medicine Institute, Shanghai Medical College, Fudan University, Shanghai, China.
Xuanyi WangInstitutes of Biomedical Sciences, Fudan University, Shanghai, China.

Funding

National Key R&D Program of China 2025YFC3408400National Natural Science Foundation of China 32370697National Science and Technology Major Projects for Significant New Drug Development of China 2018ZX09739002-006
6 · The paper itself

Abstract

A significant numerical increase of genotype GII.17 norovirus-associated sporadic infections was observed in multiple cities in China during the 2024-2025 season. We collected fecal samples from hospitalized children with acute gastroenteritis from 29 sentinel hospitals nationwide to screen for norovirus. A total of 18.7% (n = 412) of the samples tested positive, with a decrease in genotype GII.4 (27% of all positive cases) coinciding with an increase in GII.17 (62%). Comparative phylogenetic analysis of RNA-dependent RNA polymerase and capsid gene sequences revealed that these GII.17[P17] strains were most closely related to strains circulating in the United States and European countries during 2023-2024, with which they shared a recent common ancestor. The evolving epidemiology of norovirus, characterized by the circulation of multiple genotypes, highlights the need for ongoing surveillance and research to better understand its impact and guide the development of vaccines.

Indexed as

Caliciviridae InfectionsGastroenteritisGenotypeNorovirusCapsid ProteinsChildChild, PreschoolChinaCitiesFecesFemaleHumansInfantMaleMolecular EpidemiologyPhylogenyCapsid ProteinsRNA-Dependent RNA PolymeraseRNA, ViralChinagenotypingGII.17[P17] stainsmolecular epidemiologynorovirusphylogenetic analysis

Identifiers

PMID41770883
PMCPMC12952755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.